Note: Ingredients listed on restricted chemical lists
EC/CAS
77-92-9
Name of the chemical
Citric acid
Concentration
N/A
EC/CAS
5026-62-0
Name of the chemical
4-Hydroxybenzoic acid and its Methyl- and Ethyl-esters, and their salts
Concentration
N/A
EC/CAS
35285-69-9
Name of the chemical
Butyl 4-hydroxybenzoate and its salts Propyl 4-hydroxybenzoate and its salts
Concentration
N/A
EC/CAS
532-32-1
Name of the chemical
Benzoic acid and its sodium salt
Concentration
N/A
EC/CAS
57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
N/A
General Information
Revision date
2023-08-29
Product name
Famotidine for Oral Suspension USP 40 mg/5 mL
Manufacturer Name
Annora Pharma Ltd
Icons in SDS
Company Information
company name
Annora Pharma Ltd
Section 2
SECTION 2: Hazards identification
Fire and Explosion Expected to be non-combustible. Health Famotidine for oral suspension is contraindicated in patients with a history of serious hypersensitivity reactions (e.g., anaphylaxis) to famotidine or other histamine-2 (H2) receptor antagonists.
Environmental hazards
No information is available about the potential of this product to produce adverse environmental effects.